Unhealthy lifestyle impacts on biological systems involved in stress response: hypothalamic-pituitary-adrenal axis, inflammation and autonomous nervous system.
Journal
International clinical psychopharmacology
ISSN: 1473-5857
Titre abrégé: Int Clin Psychopharmacol
Pays: England
ID NLM: 8609061
Informations de publication
Date de publication:
01 05 2023
01 05 2023
Historique:
medline:
3
4
2023
pubmed:
3
2
2023
entrez:
2
2
2023
Statut:
ppublish
Résumé
An unhealthy lifestyle has a critical role in the pathogenesis and course of several chronic disorders. It has been hypothesized that lifestyle may also impact biological systems involved in stress response. A global index of unhealthy lifestyle was calculated based on the cumulative presence of five self-reported lifestyle habits (smoking, excessive alcohol use, drug use, low physical activity and short sleep) in 2783 participants (18-65 years) from the Netherlands Study of Depression and Anxiety. The functioning of biological stress systems was based on multiple physiological measures of cortisol, inflammatory cytokines and autonomic cardiac activity. The unhealthy lifestyle index was associated with hyperactivity of hypothalamus-pituitary-adrenal axis and increased inflammation, indicating that with increasing unhealthy habits, the level of biological stress increases. No association with the autonomic nervous system activity was observed; however, the use of drugs increased parasympathetic cardiac activity and significantly impacted on ANS. Results were not impacted by a recent episode of depression or anxiety disorder. An unhealthy lifestyle may unfavorably impact on biological systems involved in stress response, which may underlie progression of several psychiatric as well as somatic chronic disorders.
Identifiants
pubmed: 36730700
doi: 10.1097/YIC.0000000000000437
pii: 00004850-202305000-00002
pmc: PMC10063190
doi:
Substances chimiques
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
127-135Informations de copyright
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
Références
Andrews G, Peters L (1998). The psychometric properties of the composite international diagnostic interview. Soc Psychiatry Psychiatr Epidemiol 33:80–88.
Arena R, McNeil A, Sagner M, Hills AP (2017). The current global state of key lifestyle characteristics: health and economic implications. Prog Cardiovasc Dis 59:422–429.
Badini I, Coleman JRI, Hagenaars SP, Hotopf M, Breen G, Lewis CM, Fabbri C (2022). Depression with atypical neurovegetative symptoms shares genetic predisposition with immuno-metabolic traits and alcohol consumption. Psychol Med 52:726–736.
Barakat A, Vogelzangs N, Licht CM, Geenen R, MacFarlane GJ, de Geus EJ, et al. (2012). Dysregulation of the autonomic nervous system and its association with the presence and intensity of chronic widespread pain. Arthritis Care Res (Hoboken) 64:1209–1216.
Benedetti F, Zanardi R, Mazza MG (2022). Antidepressant psychopharmacology: is inflammation a future target? Int Clin Psychopharmacol 37:79–81.
Berk M, Williams LJ, Jacka FN, O’Neil A, Pasco JA, Moylan S, et al. (2013). So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11:200.
Berntson GG, Cacioppo JT, Binkley PF, Uchino BN, Quigley KS, Fieldstone A (1994). Autonomic cardiac control. III. Psychological stress and cardiac response in autonomic space as revealed by pharmacological blockades. Psychophysiology 31:599–608.
Besnier F, Labrunée M, Pathak A, Pavy-Le Traon A, Galès C, Sénard JM, Guiraud T (2017). Exercise training-induced modification in autonomic nervous system: an update for cardiac patients. Ann Phys Rehabil Med 60:27–35.
Blaine SK, Sinha R (2017). Alcohol, stress, and glucocorticoids: from risk to dependence and relapse in alcohol use disorders. Neuropharmacology 122:136–147.
Boschloo L, Vogelzangs N, Licht CM, Vreeburg SA, Smit JH, van den Brink W, et al. (2011). Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. Drug Alcohol Depend 116:170–176.
Carroll BJ (1984). Dexamethasone suppression test, 1984. Clin Neuropharmacol 7: S146.
Chen C, Nakagawa S, An Y, Ito K, Kitaichi Y, Kusumi I (2017). The exercise-glucocorticoid paradox: how exercise is beneficial to cognition, mood, and the brain while increasing glucocorticoid levels. Front Neuroendocrinol 44:83–102.
Coups EJ, Gaba A, Orleans CT (2004). Physician screening for multiple behavioral health risk factors. Am J Prev Med 27:34–41.
Cui C, Shurtleff D, Harris RA (2014). Neuroimmune mechanisms of alcohol and drug addiction. Int Rev Neurobiol 118:1–12.
Dörks M, Hoffmann F, Jobski K (2022). Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based study. Int Clin Psychopharmacol 37:185–192.
Duivis HE, Vogelzangs N, Kupper N, de Jonge P, Penninx BW (2013). Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology 38:1573–1585.
Edwards S, Little HJ, Richardson HN, Vendruscolo LF (2015). Divergent regulation of distinct glucocorticoid systems in alcohol dependence. Alcohol 49:811–816.
El-Khoury J, Beayno A, Elbejjani M, Abed Al Ahad M, Majari G, Ahmad A, Noufi P (2020). The association of antidepressant monotherapy and weight change in a Middle Eastern psychiatric population. Int Clin Psychopharmacol 35:201–207.
Elnazer HY, Sampson AP, Baldwin DS (2021). Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study. Int Clin Psychopharmacol 36:126–132.
Fosnocht AQ, Briand LA (2016). Substance use modulates stress reactivity: behavioral and physiological outcomes. Physiol Behav 166:32–42.
Gardner JD, Mouton AJ (2015). Alcohol effects on cardiac function. Compr Physiol 5:791–802.
Grandner MA, Seixas A, Shetty S, Shenoy S (2016). Sleep duration and diabetes risk: population trends and potential mechanisms. Curr Diab Rep 16:106.
Heller RF, O’Connell DL, Roberts DC, Allen JR, Knapp JC, Steele PL, Silove D (1988). Lifestyle factors in monozygotic and dizygotic twins. Genet Epidemiol 5:311–321.
Hidalgo-Mazzei D, Llach C, Vieta E (2020). mHealth in affective disorders: hype or hope? A focused narrative review. Int Clin Psychopharmacol 35:61–68.
Hiles S, Lamers F, Penninx B (2017). An unhealthy lifestyle index predicting longitudinal course of depression and anxiety. Psychosom Med 79:A141–A141.
Houtveen JH, Groot PF, Geus EJ (2005). Effects of variation in posture and respiration on RSA and pre-ejection period. Psychophysiology 42:713–719.
Hu MX, Lamers F, de Geus EJ, Penninx BW (2017). Influences of lifestyle factors on cardiac autonomic nervous system activity over time. Prev Med 94:12–19.
Javaheri S, Redline S (2017). Insomnia and risk of cardiovascular disease. Chest 152:435–444.
Karagueuzian HS (2008). Consensus statement from the Cardiac Nomenclature Study Group of Arrhythmias of the European Society of Cardiology, and the Task Force on Cardiac Nomenclature from the North American Society of Pacing and Electrophysiology on Living Anatomy of the Atriove. J Cardiovasc Electrophysiol 11:1298–1298.
King K, Meader N, Wright K, Graham H, Power C, Petticrew M, et al. (2015). Characteristics of interventions targeting multiple lifestyle risk behaviours in adult populations: a systematic scoping review. PLoS One 10:e0117015.
Kishioka S, Kiguchi N, Kobayashi Y, Saika F (2014). Nicotine effects and the endogenous opioid system. J Pharmacol Sci 125:117–124.
Kuzminskaite E, Vinkers CH, Elzinga BM, Wardenaar KJ, Giltay EJ, Penninx BWJH (2020). Childhood trauma and dysregulation of multiple biological stress systems in adulthood: results from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology 121:104835.
Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman AT, Penninx BW (2013). Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry 18:692–699.
Lanfranchi PA, Somers VK (2002). Arterial baroreflex function and cardiovascular variability: interactions and implications. Am J Physiol Regul Integr Comp Physiol 283:R815–R826.
Licht CM, Penninx BW, de Geus EJ (2012). Effects of antidepressants, but not psychopathology, on cardiac sympathetic control: a longitudinal study. Neuropsychopharmacology 37:2487–2495.
Lopresti AL, Hood SD, Drummond PD (2013). A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. J Affect Disord 148:12–27.
Lovallo WR (2006). Cortisol secretion patterns in addiction and addiction risk. Int J Psychophysiol 59:195–202.
Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, et al. (1998). The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10:313–318.
McEwen BS (1998). Protective and damaging effects of stress mediators. N Engl J Med 338:171–179.
Middlekauff HR, Park J, Moheimani RS (2014). Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: mechanisms and implications for cardiovascular risk. J Am Coll Cardiol 64:1740–1750.
Möller-Leimkühler AM (2010). Higher comorbidity of depression and cardiovascular disease in women: a biopsychosocial perspective. World J Biol Psychiatry 11:922–933.
Nater UM, Skoluda N, Strahler J (2013). Biomarkers of stress in behavioural medicine. Curr Opin Psychiatry 26:440–445.
Peake JM, Della Gatta P, Suzuki K, Nieman DC (2015). Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects. Exerc Immunol Rev 21:8–25.
Penninx BW, Beekman AT, Smit JH, Zitman FG, Nolen WA, Spinhoven P, et al.; NESDA Research Consortium (2008). The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 17:121–140.
Phillips C, Fahimi A (2018). Immune and neuroprotective effects of physical activity on the brain in depression. Front Neurosci 12:498.
Poortinga W (2007). The prevalence and clustering of four major lifestyle risk factors in an English adult population. Prev Med 44:124–128.
Prather AA, Vogelzangs N, Penninx BW (2015). Sleep duration, insomnia, and markers of systemic inflammation: results from the Netherlands Study of Depression and Anxiety (NESDA). J Psychiatr Res 60:95–102.
Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH (2003). Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28:916–931.
Quirk SE, Williams LJ, O’Neil A, Pasco JA, Jacka FN, Housden S, et al. (2013). The association between diet quality, dietary patterns and depression in adults: a systematic review. BMC Psychiatry 13:175.
Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24–31.
Rohleder N, Kirschbaum C (2006). The hypothalamic–pituitary–adrenal (HPA) axis in habitual smokers. Int J Psychophysiol 59:236–243.
Rom O, Avezov K, Aizenbud D, Reznick AZ (2013). Cigarette smoking and inflammation revisited. Respir Physiol Neurobiol 187:5–10.
Roth T, Roehrs T, Pies R (2007). Insomnia: pathophysiology and implications for treatment. Sleep Med Rev 11:71–79.
Sarnyai Z, Shaham Y, Heinrichs SC (2001). The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53:209–243.
Sarris J, O’Neil A, Coulson CE, Schweitzer I, Berk M (2014). Lifestyle medicine for depression. BMC Psychiatry 14:107.
Sarris J, Thomson R, Hargraves F, Eaton M, de Manincor M, Veronese N, et al. (2020). Multiple lifestyle factors and depressed mood: a cross-sectional and longitudinal analysis of the UK Biobank (N = 84,860). BMC Med 18:354.
Schuit AJ, van Loon AJ, Tijhuis M, Ocké M (2002). Clustering of lifestyle risk factors in a general adult population. Prev Med 35:219–224.
Sgoifo A, Carnevali L, Pico Alfonso MDLA, Amore M (2015). Autonomic dysfunction and heart rate variability in depression. Stress 18:343–352.
Silva DA, Peres KG, Boing AF, González-Chica DA, Peres MA (2013). Clustering of risk behaviors for chronic noncommunicable diseases: a population-based study in southern Brazil. Prev Med 56:20–24.
Sinha R (2008). Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci 1141:105–130.
Späth-Schwalbe E, Uthgenannt D, Voget G, Kern W, Born J, Fehm HL (1993). Corticotropin-releasing hormone-induced adrenocorticotropin and cortisol secretion depends on sleep and wakefulness. J Clin Endocrinol Metab 77:1170–1173.
Spiegel K, Leproult R, Van Cauter E (1999). Impact of sleep debt on metabolic and endocrine function. Lancet 354:1435–1439.
Statistics IS (2015). v. 23.0, IBM Corp. IBM SPSS Statistics for Windows, Version 23.0. Armonk: NY.
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction 88:791–804.
van Aken MO, Romijn JA, Miltenburg JA, Lentjes EG (2003). Automated measurement of salivary cortisol. Clin Chem 49:1408–1409.
van Reedt Dortland AK, Vreeburg SA, Giltay EJ, Licht CM, Vogelzangs N, van Veen T, et al. (2013). The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression. Psychoneuroendocrinology 38:209–218.
Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, et al. (2001). Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 86:3787–3794.
Vogelzangs N, Duivis HE, Beekman AT, Kluft C, Neuteboom J, Hoogendijk W, et al. (2012). Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry 2:e79.
Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, et al. (2009). Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 66:617–626.
Vreeburg SA, Hoogendijk WJ, DeRijk RH, van Dyck R, Smit JH, Zitman FG, Penninx BW (2013). Salivary cortisol levels and the 2-year course of depressive and anxiety disorders. Psychoneuroendocrinology 38:1494–1502.
Walsh R (2011). Lifestyle and mental health. Am Psychol 66:579–592.
Yasuma F, Hayano J-I (2004). Heartbeat synchronizes with respiratory rhythm only under specific circumstances. Chest 126:1386–1387.
Zhou Z, Chen P, Peng H (2016). Are healthy smokers really healthy? Tob Induc Dis 14:35.